We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
EBQ:Lactate clearance vs central venous oxygen saturation
From WikEM
incomplete Journal Club Article
Jones AE.. "Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial". JAMA. 2010. 303(8):739-746.
PubMed Full text PDF
PubMed Full text PDF
Contents
Clinical Question
Is lactate clearance as good as SVO2 as a measure of oxygen delivery to tissues in patients presenting with severe sepsis and septic shock?
Conclusion
For patients with septic shock who were treated by normalizing CVP and MAP; attempt to normalize lactate clearance as opposed to normalize SVO2 showed no significant difference in in-hospital mortality.
Major Points
Inclusion Criteria
- >17 years old AND
- confirmed or presumed infection meeting criteria for severe sepsis or septic shock:
- 2 or more SIRS criteria AND
- SBP <90 after 20 mL/kg bolus or blood lactate at least 36 mg/dL
Exclusion Criteria
- Pregnancy
- Primary diagnosis other than sepsis
- Likely surgery required within 6 hours of diagnosis
- Contraindication to chest or neck CVC
- Cardiopulmonary resuscitation
- Transfer from an institution with sepsis protocol already underway
- Advance directive restricting study protocol
Interventions
- Randomized into 1 of 2 resuscitation groups
- CVP was managed first in both groups to achieve a CVP of at least 8
- Isotonic boluses given
- SBP was managed second to maintain a MAP of at least 65
- Fluid resuscitation followed by vasopressors (dopamine and norepi)
- The groups differed in the third physiologic parameter that was targeted: SVO2 vs. lactate clearance
- SVO2 of 70%
- lactate clearance of 10%
- If hematocrit <30 and either target not achieved, PRBC transfusion to achieve hematocrit of at least 30
- If hematocrit was at least 30 and either target not achieved, then dopamine titrated to achieve effect
Outcome
*Intention to treat analysis
Primary Outcomes
- Absolute in-hospital mortality rate
- SVO2: 23%
- Lactate: 17%
- Did not reach -10% threshold
Secondary Outcomes
- ICU length of stay
- SVO2: 8.46%
- Lactate: 7.39%
- p-value = 0.75
- Hospital length of stay
- SVO2: 10.89%
- Lactate: 11.68%
- p-value = 0.60
- Ventilator-free days
- SVO2: 10.39%
- Lactate: 11.09%
- p-value = 0.67
- New onset of multiple organ failure
- SVO2: 25%
- Lactate: 22%
- p-value = 0.68